Industry | 房地产业 | ||||||||||||||||||||||||
Company Introduction | 深圳市全新好股份有限公司(证券简称:全新好;证券代码:000007;法定英文名称:ShenZhenQuanXinHaoCo.,Ltd.,以下简称“全新好”或“公司”)成立于1983年3月11日,原称“深圳市赛格达声股份有限公司”及“深圳市零七股份有限公司”,1992年4月13日公司成功在深交所挂牌上市,成为中国资本市场首批上市公众公司。在驰骋资本市场的三十多年里,公司伴随中国资本市场的发展而壮大,从最初的电子工业到房地产开发,从酒店旅游业到矿产资源开发,到近年经多轮资产重组逐步向信息技术服务业等现代新兴产业转型,企业价值已逐步显现,并得到投资者广泛认可。同时,公司依据日本eleten株式会社国际巴黎公约专利申请在中国境内(包括香港、澳门和台湾地区)进行技术推广和使用的独家授权,进一步加速向“全民大健康+高科技”新产业转型和升级,实现专利技术的高效商业化,依托科技的驱动打造大健康产业,有效改善公司产业布局和经营能力,公司未来业绩将更加辉煌,发展前景将更加广阔。 2019年底,为改善公司经营,维护全体股东合法权益,深耕资本市场多年的公司第二大股东深圳市博恒投资有限公司联合其他股东成为一致行动关系并得以入主公司。在新控股股东的大力支持和帮助下,全新好在2019年12月25日获得日本eleten株式会社国际巴黎公约专利申请(1.纳米胶囊零度分解技术;2.干式生活杀菌纸巾)在中国境内(包括香港、澳门和台湾地区)技术推广和使用权授权。该技术在日本主要应用在医学和医药领域,全新好在中国首次应用在全民卫生大健康生活用纸领域。该技术的作用是:它能将药物对人体的副作用消除掉,同时保持药物的治病功效不变,消除了过去认为“是药就有三分毒”旧观念。公司将在明年开始在深圳和广东地区向生活用纸领域的造纸商和经销商提供该技术和产品,向市场推出对人体无副作用的灭菌消毒纸巾,保障人类远离细菌,提高健康水准。 公司未来将深度贯彻国家对于大健康产业政策指导方针,致力于“全民大健康+高科技”方向的转型升级,突破传统行业模式,始终秉承“规范化、科学化、国际化、责任化”的经营管理风格,开启全民大健康时代。自《“健康中国2030”规划纲要》的颁布,我国从国家层面上提出了健康领域中长期战略规划,“健康中国”战略全面启动,大健康产业成为拉动经济发展的新引擎。此次公司业务向“全民大健康+高科技”领域的转移,是一次重要的产业升级,也是因势利导的转型变革。全新好将依托科技的驱动,积极打造大健康产业,这也是公司未来的主要发展方向。 公司的发展战略:立足国内,面向海外,通过优化产业结构,在推进重组和再融资中不断整合人才、资金、资源等多方面优势,将公司打造成为现代信息技术服务行业和高科技赋能大健康行业的上市公司新“旗舰”。 | ||||||||||||||||||||||||
Main Business | 投资兴办实业(具体项目另报);房地产开发与销售;酒店、旅游服务业;典当业务;进出口业务(国家限定公司经营和禁止进出口商品除外);国内商业、物资供销业(不含专营、专卖和专控商品)。 | ||||||||||||||||||||||||
Legal Representative | 唐乾 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 陈伟彬 | ||||||||||||||||||||||||
Solicitors | 北京市洪范广住律师事务所 | ||||||||||||||||||||||||
Auditors | 深圳鹏城会计师事务有限公司 | ||||||||||||||||||||||||
Tel No | 0755-83280053 | ||||||||||||||||||||||||
Fax No | 0755-83281722 | ||||||||||||||||||||||||
Website | www.sz000007.com | ||||||||||||||||||||||||
867904718@qq.com;stock0007@vip.126.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 13/04/1992 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 0.104 | ||||||||||||||||||||||||
DPS(RMB)* | -- | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 0.363 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 2.491B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |